KANDY / BAYER DEAL PUTS WOMEN’S HEALTHCARE SECTOR IN … · Berkeley Lights $178.2 million IPO US...
6
MONTHLY INTELLIGENCE | UPCOMING EVENTS | MEDIA DIRECTORY | CONFERENCES MONTHLY HEALTHCARE NEWSLETTER - SUMMER EDITION 2020 A GLOBAL LEADER IN STRATEGIC HEALTHCARE COMMUNICATIONS London | New York | Boston | San Francisco VISIT WWW.CONSILIUM-COMMS.COM FOR MORE INTEL KANDY / BAYER DEAL PUTS WOMEN’S HEALTHCARE SECTOR IN THE SPOTLIGHT On 11 August, KaNDy Therapeutics announced it had been acquired by Bayer Pharmaceuticals for an upfront consideration of USD 425 million, potential milestone payments of up to USD 450 million until launch followed by potential additional triple digit million sales milestone payments*. KaNDy was formed in 2017 as a spin- out from NeRRe Therapeutics by Dr Mary Kerr, CEO and Co-Founder Dr Mike Trower, CSO. With an impressive background within the life-sciences industry including senior leadership roles at ViiV Healthcare and GSK and, with a real passion for women’s healthcare, Mary was well positioned to lead KaNDy. Instrumental to the clinical development of the Company’s lead compound, Andrew Kay, Chairman of the Board, and Co-founder Dr Mike Trower, CSO, have both offered trusted and invaluable advice to KaNDy Therapeutics, alongside significant input from Dr Steve Pawsey, CMO, Rebecca Hemsley, Senior VP Finance & Operations, Jo Craig, Senior Vice President CMC and Elizabeth Ballantyne, Vice President of Clinical Operations. Mary hopes this deal will further highlight the women’s healthcare sector and the unmet need: “There is a real need for innovation and investment in the under- served field of women’s health. We hope that this acquisition will encourage investors to sit-up and take more of an interest in this space.” KaNDy is backed by a leading Mary Kerr, CEO, KaNDy Therapeutics consortium of investors including Advent Life Sciences, Fountain Healthcare Partners, Forbion Capital Partners, Longitude Capital and OrbiMed. Advent co-founded NeRRe with Mike Trower in 2012 and have been committed investors since. Kaasim Mahmood from Advent introduced Ena Prosser (Fountain) who led the NeRRe Series B. Geert- Jan Mulder (Forbion) and Dr Iain Dukes (Orbimed) also joined the syndicate at this time. Josh Richardson (Longitude) led the most recent Series C financing round in 2018 which raised £25m to fund the KaNDy Phase 2b clinical development programme. Mary and the team at KaNDy would like to thank their investors and advisors who have played a key role in building the Company that exists today. Consilium has advised KaNDy on its strategic communications since May 2018. *Closing is subject to customary conditions, anti-trust approval and is expected by September 2020. MONTHLY INTELLIGENCE MEDIA MOVES – Drew Armstrong is now senior editor for Healthcare at Bloomberg Business ANALYST MOVES – Philip Davies will be joining N+1 Singer from Cantor Fitzgerald – Mick Cooper has joined the BEIS as a life sciences analyst
Transcript of KANDY / BAYER DEAL PUTS WOMEN’S HEALTHCARE SECTOR IN … · Berkeley Lights $178.2 million IPO US...
MONTHLY INTELLIGENCE | UPCOMING EVENTS | MEDIA DIRECTORY | CONFERENCES
MONTHLY HEALTHCARE NEWSLETTER - SUMMER EDITION 2020A GLOBAL LEADER IN STRATEGIC HEALTHCARE COMMUNICATIONSLondon | New York | Boston | San Francisco
VISIT WWWCONSILIUM-COMMSCOM FOR MORE INTEL
KANDY BAYER DEAL PUTS WOMENrsquoS HEALTHCARE SECTOR IN THE SPOTLIGHT
On 11 August KaNDy Therapeutics announced it had been acquired by Bayer Pharmaceuticals for an upfront consideration of USD 425 million potential milestone payments of up to USD 450 million until launch followed by potential additional triple digit million sales milestone payments
KaNDy was formed in 2017 as a spin-out from NeRRe Therapeutics by Dr Mary Kerr CEO and Co-Founder Dr Mike Trower CSO
With an impressive background within the life-sciences industry including senior leadership roles at ViiV Healthcare and GSK and with a real passion for womenrsquos healthcare Mary was well positioned to lead KaNDy
Instrumental to the clinical development of the Companyrsquos lead compound Andrew Kay Chairman of the Board and Co-founder Dr Mike Trower CSO have both offered trusted and invaluable advice to KaNDy Therapeutics alongside significant input from Dr Steve Pawsey CMO Rebecca Hemsley Senior VP Finance amp Operations Jo Craig Senior Vice President CMC and Elizabeth Ballantyne Vice President of Clinical Operations
Mary hopes this deal will further highlight the womenrsquos healthcare sector and the unmet need ldquoThere is a real need for innovation and investment in the under-served field of womenrsquos health We hope that this acquisition will encourage investors to sit-up and take more of an interest in this spacerdquo
KaNDy is backed by a leading
Mary Kerr CEO KaNDy Therapeutics
consortium of investors including Advent Life Sciences Fountain Healthcare Partners Forbion Capital Partners Longitude Capital and OrbiMed Advent co-founded NeRRe with Mike Trower in 2012 and have been committed investors since Kaasim Mahmood from Advent introduced Ena Prosser (Fountain) who led the NeRRe Series B Geert-Jan Mulder (Forbion) and Dr Iain Dukes (Orbimed) also joined the syndicate at this time Josh Richardson (Longitude) led the most recent Series C financing round in 2018 which raised pound25m to fund the KaNDy Phase 2b clinical development programme
Mary and the team at KaNDy would like to thank their investors and advisors who have played a key role in building the Company that exists today
Consilium has advised KaNDy on its strategic communications since May 2018
Closing is subject to customary conditions anti-trust approval and is expected by September 2020
MONTHLY INTELLIGENCE
MEDIA MOVES ndash Drew Armstrong is now senior editor for Healthcare at Bloomberg Business
ANALYST MOVES ndash Philip Davies will be joining N+1 Singer from Cantor Fitzgerald ndash Mick Cooper has joined the BEIS as a life sciences analyst
THIS MONTHrsquoS MOVERS AND SHAKERS
CONSILIUM TEAMrsquoS GREEN FINGERS DURING COVID
CONNAUGHT ROOMS WC2B19 NOVEMBER
ndash Akari appointed Torsten Hombeck as CFO
ndash Khondrion appointed Herma Renkema as Chief Early Development Officer
ndash WuXi Advanced Therapies appointed David Chang as CEO
ndash Ipsen appointed David Loew as CEO ndash Aligos Therapeutics appointed Lesley Ann Calhoun as CFO
ndash Cytovia Therapeutics appointed Wei Li as acting CSO
ndash Lonza appointed Pierre-Alain Ruffieux as CEO
ndash Altasciences promoted Gaetano Morelli to CMO
ndash Dendreon Pharmaceuticals appointed Jason OrsquoNeill as CEO
ndash The UK government appointed Clive Dix as deputy chair of the UKrsquos Vaccine Taskforce
ndash X4 Pharmaceuticals promoted Renato Skerlj to CSO
ndash Larimar Therapeutics appointed Nancy Ruiz as CMO and Michael Celano as CFO
ndash Laboratory for Advanced Medicine appointed Samuel Tong as CEO of its Chinese operations
ndash Adverum Biotechnologies appointed Laurent Fischer as CEO and a member of the board of directors
ndash Nurix Therapeutics promoted Gwenn Hansen as CSO and Hans van Houte as CFO
ndash FerGene appointed Ambaw Bellete as CFO
ndash Rentschler Biopharma SE appointed
Alexander Dettmer as CFO ndash Avid Bioservices appointed Nicholas Green as president CEO and board member
ndash Moderna appointed David Meline joins as CFO
ndash Mereo BioPharma appointed John Lewicki as CSO
ndash Oncopeptides appointed Marty Duvall as CEO
ndash Lodo Therapeutics promoted Steve Colletti to CSO
ndash Notable appointed Joseph Wagner as CSO
ndash Scholar Rock appointed Tony Kingsley as CEO
ndash EyePoint Pharmaceuticals appointed Jay Duker as chief strategic scientific officer
ndash Viacyte appointed Brittany Bradrick as CFO
ndash Flagship Pioneering appointed Guillaume Pfefer as CEO-Partner
ndash Biogen appointed Michael McDonnell as CFO
ndash Rhythm Pharmaceuticals appointed David Meeker as CEO
ndash Triplet Therapeutics appointed Alan Buckler as CSO
ndash Viroclinics Biosciences appointed Davide Molho as CEO
ndash Gain Therapeutics appointed Eric Richman as CEO
ndash Generation Bio appointed Matthew Norkunas as CFO
ndash Windtree Therapeutics appointed John Hamill as senior VP and CFO
If you would like to receive our Monday Healthcare Bulletin which summarises all healthcare business news from the weekend please contact admincscconsilium-commscom
HIGHLIGHTED FUNDRAISING ACTIVITY FROM JUNE TO AUGUST 2020
COMPANY NAME AMOUNT RAISED
TYPE OF FUNDRAISE COUNTRY DATE
PUBLIC COMPANY FINANCINGS
Allogene Therapeutics $550 million Follow-on US 2-Jun-20
Adaptimmune Therapeutics $2255 million Follow-on US 2-Jun-20
Windtree Therapeutics $23 million Stock Offering US 2-Jun-20
Pliant Therapeutics $144 million IPO US 3-Jun-20
Mereo BioPharma $70 million Private Placing US 4-Jun-20
Applied Molecular Transport $154 million IPO US 4-Jun-20
Arya Sciences Acquisition $130 million IPO US 4-Jun-20
Legend Biotechnology $4238 million IPO US 5-Jun-20
Kezar Life Sciences $467 million Follow-on US 8-Jun-20
Mustang Bio $35 million Follow-on US 9-Jun-20
ChemoCentryx Inc $3016 million Follow-on US 10-Jun-20
Fate Therapeutics $175 million Follow-on US 10-Jun-20
CareDx $125 million Follow-on US 10-Jun-20
Retrophin $1008 million Follow-on US 10-Jun-20
Replimune Group $100 million Follow-on US 10-Jun-20
Immunic $25 million Follow-on US 10-Jun-20
Lantern Pharma Inc $263 million IPO US 12-Jun-20
Avidity Biosciences $2592 million IPO US 12-Jun-20
Burning Rock Biotech $2228 million IPO US 12-Jun-20
Vaxcyte $250 million IPO US 12-Jun-20
Generation Bio $200 million IPO US 12-Jun-20
Royalty Pharma $17 billion IPO US 16-Jun-20
Celldex Therapeutics $1304 million Offering US 15-Jun-20
Constellation Pharmaceuticals $1925 million Follow-on US 16-Jun-20
Forma Therapeutics Holdings $2776 million IPO US 20-Jun-20
Repare $220 million IPO US 20-Jun-20
Genetron Holdings $256 million IPO US 20-Jun-20
Progenity $100 million IPO US 20-Jun-20
Hutchison China MediTech $100 million Private Placement US 25-Jun-20
NantKwest $801 million Follow-on US 25-Jun-20
Castle Biosciences $74 million Follow-on US 25-Jun-20
Magenta Therapeutics $60 million Follow-on US 25-Jun-20
Evelo Biosciences $45 million Follow-on US 25-Jun-20
BioNTech $250 million Private Placement US 29-Jun-20
CRISPR Therapeutics $450 million Follow-on US 2-Jul-20
Acceleron Pharma $450 million Follow-on US 2-Jul-20
SK Biopharmaceuticals $800 million IPO Korea 2-Jul-20
Ascendis Pharma $600 million Follow-on US 9-Jul-20
Vir Biotechnology $300 million Follow-on US 9-Jul-20
Akero Therapeutics $1882 million Follow-on US 9-Jul-20
89bio $729 million Follow-on US 9-Jul-20
Poseida $224 million IPO US 9-Jul-20
Jiangsu Aidea Pharmaceutical $1193 million IPO China 9-Jul-20
Immunotech HK$11 billion IPO Hong Kong 10-Jul-20
OcuMension HK$16 billion IPO Hong Kong 10-Jul-20
Nkarta $252 million IPO US 10-Jul-20
Inventiva $1077 million IPO US 10-Jul-20
Relay Therapeutics $400 million IPO US 15-Jul-20
Berkeley Lights $1782 million IPO US 16-Jul-20
ALX Oncology Holdings $1615 million IPO US 16-Jul-20
Pandion Therapeutics $1350 million IPO US 16-Jul-20
Verona Pharma $200 million Private Placement US 21-Jul-20
iTeos Therapeutics $2011 million IPO US 23-July-20
AlloVir $27625 million IPO US 30-Jul-20
Source BioCentury
HIGHLIGHTED FUNDRAISING ACTIVITY FROM JUNE TO AUGUST 2020
COMPANY NAME AMOUNT RAISED
TYPE OF FUNDRAISE COUNTRY DATE
PRIVATE COMPANY FINANCINGS
Genor Biopharma $160 million Series B China 2-Jun-20
Everest Medicines $310 million Series C China 4-Jun-20
NodThera $55 million Series B UK 4-Jun-20
Athira Pharma $85 million Series B US 5-Jun-20
Cullinan Oncology $985 million Series B US 6-Jun-20
MabPlex International $706 million Series B China 8-Jun-20
Clover Biopharmaceuticals $24 million Series B-2 China 8-Jun-20
Shorla Pharma $83 million Series A Ireland 8-Jun-20
Curesponse $6 million Series A UK 8-Jun-20
DNAnexus $100 million Financing Round US 9-Jun-20
Verve Therapeutics $63 million Series A2 US 10-Jun-20
Checkmate Pharmaceuticals $85 million Series C US 11-Jun-20
Cue Health $100 million Series C US 11-Jun-20
C2i Genomics $12 million Series A US 11-Jun-20
Shattuck Labs $118 million Series B US 15-Jun-20
ImmVira Co $58 million Series B China 15-Jun-20
Glyscend $205 million Series A US 15-Jun-20
Shukun Network Technology $282 million Series B1 China 15-Jun-20
Ona Therapeutics $338 million Series A Spain 15-Jun-20
eTheRNA $382 million Series B Belgium 15-Jun-20
C4 Therapeutics $150 million Series B US 16-Jun-20
4D Molecular Therapeutics $75 million Series C US 16-Jun-20
GreenLight Biosciences $102 million Series D US 16-Jun-20
TILT Biotherapeutics euro62 million Financing Round Finland 16-Jun-20
DiogenX euro45 million Financing Round France 16-Jun-20
AsclepiX $35 million Series A US 23-Jun-20
Surrozen $50 million Series C US 23-Jun-20
Tara Biosystems $10 million Series A2 US 23-Jun-20
Enterome Bioscience $526 million Series E France 25-Jun-20
Poseida Therapeutics $110 million Series D US 26-Jun-20
Freeline Therapeutics $120 million Series C UK 30-Jun-20
Goldfinch Bio $100 million Series B US 1-Jul-20
Amylyx $30 million Series B US 2-Jul-20
Annexon $100 million Series D US 2-Jul-20
VarmX euro32 million Series B Netherlands 8-Jul-20
VelosBio $137 million Series B US 8-Jul-20
Vor Biopharma $110 million Series B US 8-Jul-20
CapitalBio Technology $113 million Pre-IPO Round China 9-Jul-20
CF PharmTech $50 million Series F China 9-Jul-20
Denovo Biopharma $835 million Series C China 9-Jul-20
Nucleai $65 million Series A Israel 9-Jul-20
Tranquis Therapeutics $30 million Series A US 10-Jul-20
Harbour BioMed $1028 million Series C US 11-Jul-20
BioAtla $725 million Series D US 16-Jul-20
Exalys Therapeutics $15 million Series A US 16-Jul-20
Virometix $79 million Series B Switzerland 16-Jul-20
CDMO Biose Industrie $342 million Financing Round France 16-Jul-20
Imvax $112 million Series C US 17-Jul-20
CureVac $126 million Private Funding Germany 21-Jul-20
Antengene $97 million Series C China 21-Jul-20
Citrine Medicine $80 million Series A China 21-Jul-20
Gain Therapeutics $10 million Series B Switzerland 21-Jul-20
Enthera $328 million Series A Italy 29-Jul-20
Source BioCentury
INVESTOR CONFERENCE AND VIRTUAL EVENT CALENDAR
2020
SEPTEMBERRW Baird Healthcare Conference (4-5 September)Wells Fargo Securities Healthcare conference (5-6 September) Citi 15th Annual BioPharma Conference (9-10 September) Goldman Sachs Annual Biotech Symposium London (11 September)Morgan Stanley Global Healthcare Conference (14-16 September) Cantor Global Healthcare Conference New York (15-17 September)Boston Biotech Week Boston (21-24 September)Sachs 20th Annual Biotech in Europe Forum Basel (21-24 September) Boston BioTech BD Conference Boston (22 September)Ladenburg Thalman Healthcare Conference New York (26 September)
OCTOBERLSX World Congress USA (7 October)ARM Cell amp Gene meeting on the Mesa (12-16 October) BIO Investor Forum 2020 (13-15 October) BIA UK Bioscience Forum (14-15 October) Cell amp Gene Therapy Manufacturing and Commercialization (19-22 October)BIO-Europe 2020 (26-29 October)
NOVEMBERFT Global Pharmaceutical and Biotechnology Conference London (9-11 November)Credit Suisse Annual Healthcare Conference Scottsdale (9-11 November) European Mediscience Awards London (10 November)Consilium Strategic Communications Annual Healthcare Conference London (16 November) Inveuro$tival Showcase London (16 November)Bryan Garnier amp Co 2020 Healthcare Conference Paris (16-17 November) Stifel Nicolaus Weisel Healthcare Conference 2020 New York (17-18 November)Jefferies Annual Healthcare Conference London (17-19 November)
DECEMBERBerenberg Bank Annual European Conference Surrey (30 November-3 December)Piper Jaffray Annual Healthcare Conference New York (1-3 December)
CONSILIUM STRATEGIC COMMUNICATIONSINTERNATIONAL HEALTHCARE COMMUNICATIONS
Leading international strategic PR and IR advisor
focused on healthcare
Trusted long-term relationships with clients
Boards and advisors
Networked across all critical
stakeholders
Europersquos largest specialist team with deep sector
knowledge
Experts across all sub-sectors
of healthcare
41 LOTHBURY | LONDON | EC2R 7HG NEW YORK | BOSTON | SAN FRANCISCO
+44 (0)20 3709 5700 infoconsilium-commscom wwwconsilium-commscom
ConsiliumHC
19 November Connaught Rooms WC2B
THIS MONTHrsquoS MOVERS AND SHAKERS
CONSILIUM TEAMrsquoS GREEN FINGERS DURING COVID
CONNAUGHT ROOMS WC2B19 NOVEMBER
ndash Akari appointed Torsten Hombeck as CFO
ndash Khondrion appointed Herma Renkema as Chief Early Development Officer
ndash WuXi Advanced Therapies appointed David Chang as CEO
ndash Ipsen appointed David Loew as CEO ndash Aligos Therapeutics appointed Lesley Ann Calhoun as CFO
ndash Cytovia Therapeutics appointed Wei Li as acting CSO
ndash Lonza appointed Pierre-Alain Ruffieux as CEO
ndash Altasciences promoted Gaetano Morelli to CMO
ndash Dendreon Pharmaceuticals appointed Jason OrsquoNeill as CEO
ndash The UK government appointed Clive Dix as deputy chair of the UKrsquos Vaccine Taskforce
ndash X4 Pharmaceuticals promoted Renato Skerlj to CSO
ndash Larimar Therapeutics appointed Nancy Ruiz as CMO and Michael Celano as CFO
ndash Laboratory for Advanced Medicine appointed Samuel Tong as CEO of its Chinese operations
ndash Adverum Biotechnologies appointed Laurent Fischer as CEO and a member of the board of directors
ndash Nurix Therapeutics promoted Gwenn Hansen as CSO and Hans van Houte as CFO
ndash FerGene appointed Ambaw Bellete as CFO
ndash Rentschler Biopharma SE appointed
Alexander Dettmer as CFO ndash Avid Bioservices appointed Nicholas Green as president CEO and board member
ndash Moderna appointed David Meline joins as CFO
ndash Mereo BioPharma appointed John Lewicki as CSO
ndash Oncopeptides appointed Marty Duvall as CEO
ndash Lodo Therapeutics promoted Steve Colletti to CSO
ndash Notable appointed Joseph Wagner as CSO
ndash Scholar Rock appointed Tony Kingsley as CEO
ndash EyePoint Pharmaceuticals appointed Jay Duker as chief strategic scientific officer
ndash Viacyte appointed Brittany Bradrick as CFO
ndash Flagship Pioneering appointed Guillaume Pfefer as CEO-Partner
ndash Biogen appointed Michael McDonnell as CFO
ndash Rhythm Pharmaceuticals appointed David Meeker as CEO
ndash Triplet Therapeutics appointed Alan Buckler as CSO
ndash Viroclinics Biosciences appointed Davide Molho as CEO
ndash Gain Therapeutics appointed Eric Richman as CEO
ndash Generation Bio appointed Matthew Norkunas as CFO
ndash Windtree Therapeutics appointed John Hamill as senior VP and CFO
If you would like to receive our Monday Healthcare Bulletin which summarises all healthcare business news from the weekend please contact admincscconsilium-commscom
HIGHLIGHTED FUNDRAISING ACTIVITY FROM JUNE TO AUGUST 2020
COMPANY NAME AMOUNT RAISED
TYPE OF FUNDRAISE COUNTRY DATE
PUBLIC COMPANY FINANCINGS
Allogene Therapeutics $550 million Follow-on US 2-Jun-20
Adaptimmune Therapeutics $2255 million Follow-on US 2-Jun-20
Windtree Therapeutics $23 million Stock Offering US 2-Jun-20
Pliant Therapeutics $144 million IPO US 3-Jun-20
Mereo BioPharma $70 million Private Placing US 4-Jun-20
Applied Molecular Transport $154 million IPO US 4-Jun-20
Arya Sciences Acquisition $130 million IPO US 4-Jun-20
Legend Biotechnology $4238 million IPO US 5-Jun-20
Kezar Life Sciences $467 million Follow-on US 8-Jun-20
Mustang Bio $35 million Follow-on US 9-Jun-20
ChemoCentryx Inc $3016 million Follow-on US 10-Jun-20
Fate Therapeutics $175 million Follow-on US 10-Jun-20
CareDx $125 million Follow-on US 10-Jun-20
Retrophin $1008 million Follow-on US 10-Jun-20
Replimune Group $100 million Follow-on US 10-Jun-20
Immunic $25 million Follow-on US 10-Jun-20
Lantern Pharma Inc $263 million IPO US 12-Jun-20
Avidity Biosciences $2592 million IPO US 12-Jun-20
Burning Rock Biotech $2228 million IPO US 12-Jun-20
Vaxcyte $250 million IPO US 12-Jun-20
Generation Bio $200 million IPO US 12-Jun-20
Royalty Pharma $17 billion IPO US 16-Jun-20
Celldex Therapeutics $1304 million Offering US 15-Jun-20
Constellation Pharmaceuticals $1925 million Follow-on US 16-Jun-20
Forma Therapeutics Holdings $2776 million IPO US 20-Jun-20
Repare $220 million IPO US 20-Jun-20
Genetron Holdings $256 million IPO US 20-Jun-20
Progenity $100 million IPO US 20-Jun-20
Hutchison China MediTech $100 million Private Placement US 25-Jun-20
NantKwest $801 million Follow-on US 25-Jun-20
Castle Biosciences $74 million Follow-on US 25-Jun-20
Magenta Therapeutics $60 million Follow-on US 25-Jun-20
Evelo Biosciences $45 million Follow-on US 25-Jun-20
BioNTech $250 million Private Placement US 29-Jun-20
CRISPR Therapeutics $450 million Follow-on US 2-Jul-20
Acceleron Pharma $450 million Follow-on US 2-Jul-20
SK Biopharmaceuticals $800 million IPO Korea 2-Jul-20
Ascendis Pharma $600 million Follow-on US 9-Jul-20
Vir Biotechnology $300 million Follow-on US 9-Jul-20
Akero Therapeutics $1882 million Follow-on US 9-Jul-20
89bio $729 million Follow-on US 9-Jul-20
Poseida $224 million IPO US 9-Jul-20
Jiangsu Aidea Pharmaceutical $1193 million IPO China 9-Jul-20
Immunotech HK$11 billion IPO Hong Kong 10-Jul-20
OcuMension HK$16 billion IPO Hong Kong 10-Jul-20
Nkarta $252 million IPO US 10-Jul-20
Inventiva $1077 million IPO US 10-Jul-20
Relay Therapeutics $400 million IPO US 15-Jul-20
Berkeley Lights $1782 million IPO US 16-Jul-20
ALX Oncology Holdings $1615 million IPO US 16-Jul-20
Pandion Therapeutics $1350 million IPO US 16-Jul-20
Verona Pharma $200 million Private Placement US 21-Jul-20
iTeos Therapeutics $2011 million IPO US 23-July-20
AlloVir $27625 million IPO US 30-Jul-20
Source BioCentury
HIGHLIGHTED FUNDRAISING ACTIVITY FROM JUNE TO AUGUST 2020
COMPANY NAME AMOUNT RAISED
TYPE OF FUNDRAISE COUNTRY DATE
PRIVATE COMPANY FINANCINGS
Genor Biopharma $160 million Series B China 2-Jun-20
Everest Medicines $310 million Series C China 4-Jun-20
NodThera $55 million Series B UK 4-Jun-20
Athira Pharma $85 million Series B US 5-Jun-20
Cullinan Oncology $985 million Series B US 6-Jun-20
MabPlex International $706 million Series B China 8-Jun-20
Clover Biopharmaceuticals $24 million Series B-2 China 8-Jun-20
Shorla Pharma $83 million Series A Ireland 8-Jun-20
Curesponse $6 million Series A UK 8-Jun-20
DNAnexus $100 million Financing Round US 9-Jun-20
Verve Therapeutics $63 million Series A2 US 10-Jun-20
Checkmate Pharmaceuticals $85 million Series C US 11-Jun-20
Cue Health $100 million Series C US 11-Jun-20
C2i Genomics $12 million Series A US 11-Jun-20
Shattuck Labs $118 million Series B US 15-Jun-20
ImmVira Co $58 million Series B China 15-Jun-20
Glyscend $205 million Series A US 15-Jun-20
Shukun Network Technology $282 million Series B1 China 15-Jun-20
Ona Therapeutics $338 million Series A Spain 15-Jun-20
eTheRNA $382 million Series B Belgium 15-Jun-20
C4 Therapeutics $150 million Series B US 16-Jun-20
4D Molecular Therapeutics $75 million Series C US 16-Jun-20
GreenLight Biosciences $102 million Series D US 16-Jun-20
TILT Biotherapeutics euro62 million Financing Round Finland 16-Jun-20
DiogenX euro45 million Financing Round France 16-Jun-20
AsclepiX $35 million Series A US 23-Jun-20
Surrozen $50 million Series C US 23-Jun-20
Tara Biosystems $10 million Series A2 US 23-Jun-20
Enterome Bioscience $526 million Series E France 25-Jun-20
Poseida Therapeutics $110 million Series D US 26-Jun-20
Freeline Therapeutics $120 million Series C UK 30-Jun-20
Goldfinch Bio $100 million Series B US 1-Jul-20
Amylyx $30 million Series B US 2-Jul-20
Annexon $100 million Series D US 2-Jul-20
VarmX euro32 million Series B Netherlands 8-Jul-20
VelosBio $137 million Series B US 8-Jul-20
Vor Biopharma $110 million Series B US 8-Jul-20
CapitalBio Technology $113 million Pre-IPO Round China 9-Jul-20
CF PharmTech $50 million Series F China 9-Jul-20
Denovo Biopharma $835 million Series C China 9-Jul-20
Nucleai $65 million Series A Israel 9-Jul-20
Tranquis Therapeutics $30 million Series A US 10-Jul-20
Harbour BioMed $1028 million Series C US 11-Jul-20
BioAtla $725 million Series D US 16-Jul-20
Exalys Therapeutics $15 million Series A US 16-Jul-20
Virometix $79 million Series B Switzerland 16-Jul-20
CDMO Biose Industrie $342 million Financing Round France 16-Jul-20
Imvax $112 million Series C US 17-Jul-20
CureVac $126 million Private Funding Germany 21-Jul-20
Antengene $97 million Series C China 21-Jul-20
Citrine Medicine $80 million Series A China 21-Jul-20
Gain Therapeutics $10 million Series B Switzerland 21-Jul-20
Enthera $328 million Series A Italy 29-Jul-20
Source BioCentury
INVESTOR CONFERENCE AND VIRTUAL EVENT CALENDAR
2020
SEPTEMBERRW Baird Healthcare Conference (4-5 September)Wells Fargo Securities Healthcare conference (5-6 September) Citi 15th Annual BioPharma Conference (9-10 September) Goldman Sachs Annual Biotech Symposium London (11 September)Morgan Stanley Global Healthcare Conference (14-16 September) Cantor Global Healthcare Conference New York (15-17 September)Boston Biotech Week Boston (21-24 September)Sachs 20th Annual Biotech in Europe Forum Basel (21-24 September) Boston BioTech BD Conference Boston (22 September)Ladenburg Thalman Healthcare Conference New York (26 September)
OCTOBERLSX World Congress USA (7 October)ARM Cell amp Gene meeting on the Mesa (12-16 October) BIO Investor Forum 2020 (13-15 October) BIA UK Bioscience Forum (14-15 October) Cell amp Gene Therapy Manufacturing and Commercialization (19-22 October)BIO-Europe 2020 (26-29 October)
NOVEMBERFT Global Pharmaceutical and Biotechnology Conference London (9-11 November)Credit Suisse Annual Healthcare Conference Scottsdale (9-11 November) European Mediscience Awards London (10 November)Consilium Strategic Communications Annual Healthcare Conference London (16 November) Inveuro$tival Showcase London (16 November)Bryan Garnier amp Co 2020 Healthcare Conference Paris (16-17 November) Stifel Nicolaus Weisel Healthcare Conference 2020 New York (17-18 November)Jefferies Annual Healthcare Conference London (17-19 November)
DECEMBERBerenberg Bank Annual European Conference Surrey (30 November-3 December)Piper Jaffray Annual Healthcare Conference New York (1-3 December)
CONSILIUM STRATEGIC COMMUNICATIONSINTERNATIONAL HEALTHCARE COMMUNICATIONS
Leading international strategic PR and IR advisor
focused on healthcare
Trusted long-term relationships with clients
Boards and advisors
Networked across all critical
stakeholders
Europersquos largest specialist team with deep sector
knowledge
Experts across all sub-sectors
of healthcare
41 LOTHBURY | LONDON | EC2R 7HG NEW YORK | BOSTON | SAN FRANCISCO
+44 (0)20 3709 5700 infoconsilium-commscom wwwconsilium-commscom
ConsiliumHC
19 November Connaught Rooms WC2B
HIGHLIGHTED FUNDRAISING ACTIVITY FROM JUNE TO AUGUST 2020
COMPANY NAME AMOUNT RAISED
TYPE OF FUNDRAISE COUNTRY DATE
PUBLIC COMPANY FINANCINGS
Allogene Therapeutics $550 million Follow-on US 2-Jun-20
Adaptimmune Therapeutics $2255 million Follow-on US 2-Jun-20
Windtree Therapeutics $23 million Stock Offering US 2-Jun-20
Pliant Therapeutics $144 million IPO US 3-Jun-20
Mereo BioPharma $70 million Private Placing US 4-Jun-20
Applied Molecular Transport $154 million IPO US 4-Jun-20
Arya Sciences Acquisition $130 million IPO US 4-Jun-20
Legend Biotechnology $4238 million IPO US 5-Jun-20
Kezar Life Sciences $467 million Follow-on US 8-Jun-20
Mustang Bio $35 million Follow-on US 9-Jun-20
ChemoCentryx Inc $3016 million Follow-on US 10-Jun-20
Fate Therapeutics $175 million Follow-on US 10-Jun-20
CareDx $125 million Follow-on US 10-Jun-20
Retrophin $1008 million Follow-on US 10-Jun-20
Replimune Group $100 million Follow-on US 10-Jun-20
Immunic $25 million Follow-on US 10-Jun-20
Lantern Pharma Inc $263 million IPO US 12-Jun-20
Avidity Biosciences $2592 million IPO US 12-Jun-20
Burning Rock Biotech $2228 million IPO US 12-Jun-20
Vaxcyte $250 million IPO US 12-Jun-20
Generation Bio $200 million IPO US 12-Jun-20
Royalty Pharma $17 billion IPO US 16-Jun-20
Celldex Therapeutics $1304 million Offering US 15-Jun-20
Constellation Pharmaceuticals $1925 million Follow-on US 16-Jun-20
Forma Therapeutics Holdings $2776 million IPO US 20-Jun-20
Repare $220 million IPO US 20-Jun-20
Genetron Holdings $256 million IPO US 20-Jun-20
Progenity $100 million IPO US 20-Jun-20
Hutchison China MediTech $100 million Private Placement US 25-Jun-20
NantKwest $801 million Follow-on US 25-Jun-20
Castle Biosciences $74 million Follow-on US 25-Jun-20
Magenta Therapeutics $60 million Follow-on US 25-Jun-20
Evelo Biosciences $45 million Follow-on US 25-Jun-20
BioNTech $250 million Private Placement US 29-Jun-20
CRISPR Therapeutics $450 million Follow-on US 2-Jul-20
Acceleron Pharma $450 million Follow-on US 2-Jul-20
SK Biopharmaceuticals $800 million IPO Korea 2-Jul-20
Ascendis Pharma $600 million Follow-on US 9-Jul-20
Vir Biotechnology $300 million Follow-on US 9-Jul-20
Akero Therapeutics $1882 million Follow-on US 9-Jul-20
89bio $729 million Follow-on US 9-Jul-20
Poseida $224 million IPO US 9-Jul-20
Jiangsu Aidea Pharmaceutical $1193 million IPO China 9-Jul-20
Immunotech HK$11 billion IPO Hong Kong 10-Jul-20
OcuMension HK$16 billion IPO Hong Kong 10-Jul-20
Nkarta $252 million IPO US 10-Jul-20
Inventiva $1077 million IPO US 10-Jul-20
Relay Therapeutics $400 million IPO US 15-Jul-20
Berkeley Lights $1782 million IPO US 16-Jul-20
ALX Oncology Holdings $1615 million IPO US 16-Jul-20
Pandion Therapeutics $1350 million IPO US 16-Jul-20
Verona Pharma $200 million Private Placement US 21-Jul-20
iTeos Therapeutics $2011 million IPO US 23-July-20
AlloVir $27625 million IPO US 30-Jul-20
Source BioCentury
HIGHLIGHTED FUNDRAISING ACTIVITY FROM JUNE TO AUGUST 2020
COMPANY NAME AMOUNT RAISED
TYPE OF FUNDRAISE COUNTRY DATE
PRIVATE COMPANY FINANCINGS
Genor Biopharma $160 million Series B China 2-Jun-20
Everest Medicines $310 million Series C China 4-Jun-20
NodThera $55 million Series B UK 4-Jun-20
Athira Pharma $85 million Series B US 5-Jun-20
Cullinan Oncology $985 million Series B US 6-Jun-20
MabPlex International $706 million Series B China 8-Jun-20
Clover Biopharmaceuticals $24 million Series B-2 China 8-Jun-20
Shorla Pharma $83 million Series A Ireland 8-Jun-20
Curesponse $6 million Series A UK 8-Jun-20
DNAnexus $100 million Financing Round US 9-Jun-20
Verve Therapeutics $63 million Series A2 US 10-Jun-20
Checkmate Pharmaceuticals $85 million Series C US 11-Jun-20
Cue Health $100 million Series C US 11-Jun-20
C2i Genomics $12 million Series A US 11-Jun-20
Shattuck Labs $118 million Series B US 15-Jun-20
ImmVira Co $58 million Series B China 15-Jun-20
Glyscend $205 million Series A US 15-Jun-20
Shukun Network Technology $282 million Series B1 China 15-Jun-20
Ona Therapeutics $338 million Series A Spain 15-Jun-20
eTheRNA $382 million Series B Belgium 15-Jun-20
C4 Therapeutics $150 million Series B US 16-Jun-20
4D Molecular Therapeutics $75 million Series C US 16-Jun-20
GreenLight Biosciences $102 million Series D US 16-Jun-20
TILT Biotherapeutics euro62 million Financing Round Finland 16-Jun-20
DiogenX euro45 million Financing Round France 16-Jun-20
AsclepiX $35 million Series A US 23-Jun-20
Surrozen $50 million Series C US 23-Jun-20
Tara Biosystems $10 million Series A2 US 23-Jun-20
Enterome Bioscience $526 million Series E France 25-Jun-20
Poseida Therapeutics $110 million Series D US 26-Jun-20
Freeline Therapeutics $120 million Series C UK 30-Jun-20
Goldfinch Bio $100 million Series B US 1-Jul-20
Amylyx $30 million Series B US 2-Jul-20
Annexon $100 million Series D US 2-Jul-20
VarmX euro32 million Series B Netherlands 8-Jul-20
VelosBio $137 million Series B US 8-Jul-20
Vor Biopharma $110 million Series B US 8-Jul-20
CapitalBio Technology $113 million Pre-IPO Round China 9-Jul-20
CF PharmTech $50 million Series F China 9-Jul-20
Denovo Biopharma $835 million Series C China 9-Jul-20
Nucleai $65 million Series A Israel 9-Jul-20
Tranquis Therapeutics $30 million Series A US 10-Jul-20
Harbour BioMed $1028 million Series C US 11-Jul-20
BioAtla $725 million Series D US 16-Jul-20
Exalys Therapeutics $15 million Series A US 16-Jul-20
Virometix $79 million Series B Switzerland 16-Jul-20
CDMO Biose Industrie $342 million Financing Round France 16-Jul-20
Imvax $112 million Series C US 17-Jul-20
CureVac $126 million Private Funding Germany 21-Jul-20
Antengene $97 million Series C China 21-Jul-20
Citrine Medicine $80 million Series A China 21-Jul-20
Gain Therapeutics $10 million Series B Switzerland 21-Jul-20
Enthera $328 million Series A Italy 29-Jul-20
Source BioCentury
INVESTOR CONFERENCE AND VIRTUAL EVENT CALENDAR
2020
SEPTEMBERRW Baird Healthcare Conference (4-5 September)Wells Fargo Securities Healthcare conference (5-6 September) Citi 15th Annual BioPharma Conference (9-10 September) Goldman Sachs Annual Biotech Symposium London (11 September)Morgan Stanley Global Healthcare Conference (14-16 September) Cantor Global Healthcare Conference New York (15-17 September)Boston Biotech Week Boston (21-24 September)Sachs 20th Annual Biotech in Europe Forum Basel (21-24 September) Boston BioTech BD Conference Boston (22 September)Ladenburg Thalman Healthcare Conference New York (26 September)
OCTOBERLSX World Congress USA (7 October)ARM Cell amp Gene meeting on the Mesa (12-16 October) BIO Investor Forum 2020 (13-15 October) BIA UK Bioscience Forum (14-15 October) Cell amp Gene Therapy Manufacturing and Commercialization (19-22 October)BIO-Europe 2020 (26-29 October)
NOVEMBERFT Global Pharmaceutical and Biotechnology Conference London (9-11 November)Credit Suisse Annual Healthcare Conference Scottsdale (9-11 November) European Mediscience Awards London (10 November)Consilium Strategic Communications Annual Healthcare Conference London (16 November) Inveuro$tival Showcase London (16 November)Bryan Garnier amp Co 2020 Healthcare Conference Paris (16-17 November) Stifel Nicolaus Weisel Healthcare Conference 2020 New York (17-18 November)Jefferies Annual Healthcare Conference London (17-19 November)
DECEMBERBerenberg Bank Annual European Conference Surrey (30 November-3 December)Piper Jaffray Annual Healthcare Conference New York (1-3 December)
CONSILIUM STRATEGIC COMMUNICATIONSINTERNATIONAL HEALTHCARE COMMUNICATIONS
Leading international strategic PR and IR advisor
focused on healthcare
Trusted long-term relationships with clients
Boards and advisors
Networked across all critical
stakeholders
Europersquos largest specialist team with deep sector
knowledge
Experts across all sub-sectors
of healthcare
41 LOTHBURY | LONDON | EC2R 7HG NEW YORK | BOSTON | SAN FRANCISCO
+44 (0)20 3709 5700 infoconsilium-commscom wwwconsilium-commscom
ConsiliumHC
19 November Connaught Rooms WC2B
HIGHLIGHTED FUNDRAISING ACTIVITY FROM JUNE TO AUGUST 2020
COMPANY NAME AMOUNT RAISED
TYPE OF FUNDRAISE COUNTRY DATE
PRIVATE COMPANY FINANCINGS
Genor Biopharma $160 million Series B China 2-Jun-20
Everest Medicines $310 million Series C China 4-Jun-20
NodThera $55 million Series B UK 4-Jun-20
Athira Pharma $85 million Series B US 5-Jun-20
Cullinan Oncology $985 million Series B US 6-Jun-20
MabPlex International $706 million Series B China 8-Jun-20
Clover Biopharmaceuticals $24 million Series B-2 China 8-Jun-20
Shorla Pharma $83 million Series A Ireland 8-Jun-20
Curesponse $6 million Series A UK 8-Jun-20
DNAnexus $100 million Financing Round US 9-Jun-20
Verve Therapeutics $63 million Series A2 US 10-Jun-20
Checkmate Pharmaceuticals $85 million Series C US 11-Jun-20
Cue Health $100 million Series C US 11-Jun-20
C2i Genomics $12 million Series A US 11-Jun-20
Shattuck Labs $118 million Series B US 15-Jun-20
ImmVira Co $58 million Series B China 15-Jun-20
Glyscend $205 million Series A US 15-Jun-20
Shukun Network Technology $282 million Series B1 China 15-Jun-20
Ona Therapeutics $338 million Series A Spain 15-Jun-20
eTheRNA $382 million Series B Belgium 15-Jun-20
C4 Therapeutics $150 million Series B US 16-Jun-20
4D Molecular Therapeutics $75 million Series C US 16-Jun-20
GreenLight Biosciences $102 million Series D US 16-Jun-20
TILT Biotherapeutics euro62 million Financing Round Finland 16-Jun-20
DiogenX euro45 million Financing Round France 16-Jun-20
AsclepiX $35 million Series A US 23-Jun-20
Surrozen $50 million Series C US 23-Jun-20
Tara Biosystems $10 million Series A2 US 23-Jun-20
Enterome Bioscience $526 million Series E France 25-Jun-20
Poseida Therapeutics $110 million Series D US 26-Jun-20
Freeline Therapeutics $120 million Series C UK 30-Jun-20
Goldfinch Bio $100 million Series B US 1-Jul-20
Amylyx $30 million Series B US 2-Jul-20
Annexon $100 million Series D US 2-Jul-20
VarmX euro32 million Series B Netherlands 8-Jul-20
VelosBio $137 million Series B US 8-Jul-20
Vor Biopharma $110 million Series B US 8-Jul-20
CapitalBio Technology $113 million Pre-IPO Round China 9-Jul-20
CF PharmTech $50 million Series F China 9-Jul-20
Denovo Biopharma $835 million Series C China 9-Jul-20
Nucleai $65 million Series A Israel 9-Jul-20
Tranquis Therapeutics $30 million Series A US 10-Jul-20
Harbour BioMed $1028 million Series C US 11-Jul-20
BioAtla $725 million Series D US 16-Jul-20
Exalys Therapeutics $15 million Series A US 16-Jul-20
Virometix $79 million Series B Switzerland 16-Jul-20
CDMO Biose Industrie $342 million Financing Round France 16-Jul-20
Imvax $112 million Series C US 17-Jul-20
CureVac $126 million Private Funding Germany 21-Jul-20
Antengene $97 million Series C China 21-Jul-20
Citrine Medicine $80 million Series A China 21-Jul-20
Gain Therapeutics $10 million Series B Switzerland 21-Jul-20
Enthera $328 million Series A Italy 29-Jul-20
Source BioCentury
INVESTOR CONFERENCE AND VIRTUAL EVENT CALENDAR
2020
SEPTEMBERRW Baird Healthcare Conference (4-5 September)Wells Fargo Securities Healthcare conference (5-6 September) Citi 15th Annual BioPharma Conference (9-10 September) Goldman Sachs Annual Biotech Symposium London (11 September)Morgan Stanley Global Healthcare Conference (14-16 September) Cantor Global Healthcare Conference New York (15-17 September)Boston Biotech Week Boston (21-24 September)Sachs 20th Annual Biotech in Europe Forum Basel (21-24 September) Boston BioTech BD Conference Boston (22 September)Ladenburg Thalman Healthcare Conference New York (26 September)
OCTOBERLSX World Congress USA (7 October)ARM Cell amp Gene meeting on the Mesa (12-16 October) BIO Investor Forum 2020 (13-15 October) BIA UK Bioscience Forum (14-15 October) Cell amp Gene Therapy Manufacturing and Commercialization (19-22 October)BIO-Europe 2020 (26-29 October)
NOVEMBERFT Global Pharmaceutical and Biotechnology Conference London (9-11 November)Credit Suisse Annual Healthcare Conference Scottsdale (9-11 November) European Mediscience Awards London (10 November)Consilium Strategic Communications Annual Healthcare Conference London (16 November) Inveuro$tival Showcase London (16 November)Bryan Garnier amp Co 2020 Healthcare Conference Paris (16-17 November) Stifel Nicolaus Weisel Healthcare Conference 2020 New York (17-18 November)Jefferies Annual Healthcare Conference London (17-19 November)
DECEMBERBerenberg Bank Annual European Conference Surrey (30 November-3 December)Piper Jaffray Annual Healthcare Conference New York (1-3 December)
CONSILIUM STRATEGIC COMMUNICATIONSINTERNATIONAL HEALTHCARE COMMUNICATIONS
Leading international strategic PR and IR advisor
focused on healthcare
Trusted long-term relationships with clients
Boards and advisors
Networked across all critical
stakeholders
Europersquos largest specialist team with deep sector
knowledge
Experts across all sub-sectors
of healthcare
41 LOTHBURY | LONDON | EC2R 7HG NEW YORK | BOSTON | SAN FRANCISCO
+44 (0)20 3709 5700 infoconsilium-commscom wwwconsilium-commscom
ConsiliumHC
19 November Connaught Rooms WC2B
INVESTOR CONFERENCE AND VIRTUAL EVENT CALENDAR
2020
SEPTEMBERRW Baird Healthcare Conference (4-5 September)Wells Fargo Securities Healthcare conference (5-6 September) Citi 15th Annual BioPharma Conference (9-10 September) Goldman Sachs Annual Biotech Symposium London (11 September)Morgan Stanley Global Healthcare Conference (14-16 September) Cantor Global Healthcare Conference New York (15-17 September)Boston Biotech Week Boston (21-24 September)Sachs 20th Annual Biotech in Europe Forum Basel (21-24 September) Boston BioTech BD Conference Boston (22 September)Ladenburg Thalman Healthcare Conference New York (26 September)
OCTOBERLSX World Congress USA (7 October)ARM Cell amp Gene meeting on the Mesa (12-16 October) BIO Investor Forum 2020 (13-15 October) BIA UK Bioscience Forum (14-15 October) Cell amp Gene Therapy Manufacturing and Commercialization (19-22 October)BIO-Europe 2020 (26-29 October)
NOVEMBERFT Global Pharmaceutical and Biotechnology Conference London (9-11 November)Credit Suisse Annual Healthcare Conference Scottsdale (9-11 November) European Mediscience Awards London (10 November)Consilium Strategic Communications Annual Healthcare Conference London (16 November) Inveuro$tival Showcase London (16 November)Bryan Garnier amp Co 2020 Healthcare Conference Paris (16-17 November) Stifel Nicolaus Weisel Healthcare Conference 2020 New York (17-18 November)Jefferies Annual Healthcare Conference London (17-19 November)
DECEMBERBerenberg Bank Annual European Conference Surrey (30 November-3 December)Piper Jaffray Annual Healthcare Conference New York (1-3 December)
CONSILIUM STRATEGIC COMMUNICATIONSINTERNATIONAL HEALTHCARE COMMUNICATIONS
Leading international strategic PR and IR advisor
focused on healthcare
Trusted long-term relationships with clients
Boards and advisors
Networked across all critical
stakeholders
Europersquos largest specialist team with deep sector
knowledge
Experts across all sub-sectors
of healthcare
41 LOTHBURY | LONDON | EC2R 7HG NEW YORK | BOSTON | SAN FRANCISCO
+44 (0)20 3709 5700 infoconsilium-commscom wwwconsilium-commscom
ConsiliumHC
19 November Connaught Rooms WC2B
CONSILIUM STRATEGIC COMMUNICATIONSINTERNATIONAL HEALTHCARE COMMUNICATIONS
Leading international strategic PR and IR advisor
focused on healthcare
Trusted long-term relationships with clients
Boards and advisors
Networked across all critical
stakeholders
Europersquos largest specialist team with deep sector
knowledge
Experts across all sub-sectors
of healthcare
41 LOTHBURY | LONDON | EC2R 7HG NEW YORK | BOSTON | SAN FRANCISCO
+44 (0)20 3709 5700 infoconsilium-commscom wwwconsilium-commscom
ConsiliumHC
19 November Connaught Rooms WC2B
